AIM
FULC icon

Aigen Investment Management’s Fulcrum Therapeutics FULC Stock Holding History

Aigen Investment Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Buy
+29,512
New +$180K 0.03% 471
2024
Q3 		– Sell
-19,311
Closed -$120K – 825
2024
Q2 		$120K Buy
+19,311
New +$146K 0.02% 684

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Aigen Investment Management's FULC Position: Q2 2026 in Review

Aigen Investment Management opened a new position in Fulcrum Therapeutics (FULC) in Q2 2026: 29,512 shares worth $108K. The stake represents 0.03% of the portfolio and ranks #471 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in FULC as recently as Q2 2024.

Aigen Investment Management first reported a position in FULC in Q2 2024 and has held it in 2 quarters since. The position peaked at $120K in Q2 2024. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Aigen Investment Management held 29,512 shares of Fulcrum Therapeutics worth $108K as of Q2 2026.
  • Fulcrum Therapeutics was a new Aigen Investment Management position in Q2 2026.
  • Fulcrum Therapeutics made up 0.03% of Aigen Investment Management's portfolio in Q2 2026, its #471 holding.
  • Aigen Investment Management first reported a position in Fulcrum Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • Aigen Investment Management's Fulcrum Therapeutics position peaked at $120K in Q2 2024.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.